Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Athira Pharma | 97 | 2023q3 | |||||||||
Palo Alto Networks | 85,700 | 2023 | |||||||||
Achilles Therapeutics | 52 | 2023q3 | |||||||||
Galera Therapeutics | 6 | 2021 | |||||||||
Quince Therapeutics | 36 | 2021 | |||||||||
Cassava Sciences | 793 | 2021 | |||||||||
Fusion Fuel Green | 124 | 2021q1 | |||||||||
Prelude Therapeutics | 258 | 2023q2 | |||||||||
Check-Cap | 195 | 2021 | |||||||||
Rocket Pharmaceuticals | 2,453 | 2023q3 | |||||||||
Passage Bio | 63 | 2023q3 | |||||||||
Desert Gold Ventures | 10 | 2021 | |||||||||
Digital World Acquisition... | 1,373 | 2023q3 | |||||||||
Telo Genomics | 6 | 2022 | |||||||||
Ocugen | 299 | 2022 | |||||||||
Vor Biopharma | 131 | 2023q3 | |||||||||
Vivani Medical | 101 | 2021 | |||||||||
Solid Biosciences | 277 | 2023q3 | |||||||||
BioLineRx | 2,070 | 2021 | |||||||||
Kinnate Biopharma | 123 | 2022 |